Skip to main content
Fig. 1 | Journal of Pharmaceutical Health Care and Sciences

Fig. 1

From: Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report

Fig. 1

Clinical course of the patient. Trough plasma infliximab (IFX, open circle), immunoglobulin G (IgG, closed circle) and C-reactive protein levels (CRP, open triangle) levels are shown. IFX was administered at 5 mg/kg (days 0 and 10), 10 mg/kg (day 23), and thereafter at 8 mg/kg at 2-week intervals. Immunoglobulin (2.5 g) was administered on days 17, 31, 37, 45, 51, 59, 65, 72, 85 and thereafter once a week for at least a few months. Gray circles represent the escalation of CRP on days 87 and 126 due to infections

Back to article page